Detalhe da pesquisa
1.
The varying extent of humoral and cellular immune responses to either vector- or RNA-based SARS-CoV-2 vaccines persists for at least 18 months and is independent of infection.
J Virol
; 98(4): e0191223, 2024 Apr 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38501661
2.
PREVALENCE OF SARS-CoV-2 RNA AND ANTIBODY DETECTION, AND VACCINATION STATUS IN PATIENTS WITH OCULAR VASCULAR OCCLUSION.
Retina
; 43(11): 1951-1959, 2023 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37535933
3.
Single-dose SARS-CoV-2 vaccinations with either BNT162b2 or AZD1222 induce disparate Th1 responses and IgA production.
BMC Med
; 20(1): 29, 2022 01 19.
Artigo
Inglês
| MEDLINE | ID: mdl-35042529
4.
Comparative analysis of ChAdOx1 nCoV-19 and Ad26.COV2.S SARS-CoV-2 vector vaccines.
Haematologica
; 107(4): 947-957, 2022 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35045692
5.
Complications of influenza in 272 adult and pediatric patients in a German university hospital during the seasonal epidemic 2017-2018.
Wien Med Wochenschr
; 172(11-12): 280-286, 2022 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-34581968
6.
Human serum activates the tegument of female schistosomes and supports recovery from Praziquantel.
Parasitol Res
; 120(1): 209-221, 2021 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-33263166
7.
[Challenges of the COVID-19 Pandemic for Schools in Mecklenburg-Vorpommern - First Results of a Prospective Case Study]. / Herausforderungen der COVID-19-Pandemie für Schulen in Mecklenburg-Vorpommern erste Ergebnisse einer prospektiven Fallstudie.
Gesundheitswesen
; 83(11): 890-893, 2021 Nov.
Artigo
Alemão
| MEDLINE | ID: mdl-34571553
8.
Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial.
Lancet
; 392(10165): 2718-2727, 2019 12 22.
Artigo
Inglês
| MEDLINE | ID: mdl-30409443
9.
[COVID-19: epidemiology and clinical facts]. / COVID-19: Epidemiologische und klinische Fakten.
Radiologe
; 60(10): 893-898, 2020 Oct.
Artigo
Alemão
| MEDLINE | ID: mdl-32865603
10.
Crimean-Congo Hemorrhagic Fever, Kosovo, 2013-2016.
Emerg Infect Dis
; 25(2): 321-324, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30666932
11.
A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adults.
Infection
; 47(1): 105-109, 2019 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-30298473
12.
Tuberculosis-associated hemophagocytic lymphohistiocytosis with subsequent unmasking cryptococcal immune reconstitution inflammatory syndrome (IRIS) in an HIV-negative man.
Infection
; 47(1): 129-133, 2019 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-30259307
13.
Tuberculosis and Takayasu arteritis: case-based review.
Rheumatol Int
; 39(2): 345-351, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30607506
14.
[Mediastinal Lymphadenopathy - Tuberculosis or Tularemia?] / Mediastinale Lymphadenopathie Tuberkulose oder Tularämie?
Laryngorhinootologie
; 101(7): 594-596, 2022 07.
Artigo
Alemão
| MEDLINE | ID: mdl-35738272
15.
24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis.
J Hepatol
; 62(4): 871-8, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25463533
16.
[Gastrointestinal symptoms may reflect complicated falciparum malaria]. / Gastrointestinale Symptome als Ausdruck einer komplizierten Malaria tropica.
Dtsch Med Wochenschr
; 149(8): 454-457, 2024 Apr.
Artigo
Alemão
| MEDLINE | ID: mdl-38565119
17.
NVX-CoV2373 induces humoral and cellular immune responses that are functionally comparable to vector and mRNA-based vaccines.
Front Immunol
; 15: 1359475, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38562927
18.
Safety, Tolerability, and Immunogenicity of aH5N1 Vaccine in Adults with and without Underlying Medical Conditions.
Vaccines (Basel)
; 12(5)2024 Apr 30.
Artigo
Inglês
| MEDLINE | ID: mdl-38793732
19.
Utilization of a highly adaptable murine air pouch model for minimally invasive testing of the inflammatory potential of biomaterials.
Front Bioeng Biotechnol
; 12: 1367366, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38737540
20.
Safety and immunogenicity of Ad26.COV2.S in adults: A randomised, double-blind, placebo-controlled Phase 2a dose-finding study.
Vaccine
; 42(16): 3536-3546, 2024 Jun 11.
Artigo
Inglês
| MEDLINE | ID: mdl-38705804